RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)-Reference-Cited by-同舟云学术

RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)

Published:2011-10-07 Issue:5 Volume:52 Page:1126-1136
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Despotovic Jenny M.,Lambert Michele P.,Herman Jay H.,Gernsheimer Terry B.,McCrae Keith R.,Tarantino Michael D.,Bussel James B.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2011.03384.x/fullpdf

Reference66 articles.

1. Immune thrombocytopenic purpura;Cines;N Engl J Med,2002

2. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance;Ballem;J Clin Invest,1987

3. Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle;Rank;Biologics,2010

4. Recent progress in understanding the pathogenesis of immune thrombocytopenia;Semple;Curr Opin Hematol,2010

5. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity;Semple;Blood,1996

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Immune Thrombocytopenia;Advances in Pediatrics;2024-08

2. Immune thrombocytopenia;The Rose and Mackay Textbook of Autoimmune Diseases;2024

3. Why should intramuscular anti‐D be different from intravenous anti‐D?;British Journal of Haematology;2022-11-21

4. Immune thrombocytopenia: A review of upfront treatment strategies;Blood Reviews;2021-09

5. Blood derivative therapy;Annals of Blood;2021-01